Delivery Order SPE2DB22D3301-SPE2DB24FY4RM
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of dihydroergotamine 1 mg/ml ampule, a medication used to treat migraines. The contract has a ceiling value of $3,610.35 and runs through March 13, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,486.52 firm fixed-price delivery order contract is for the supply of dihydroergotamine 1 mg/ml ampules. The contract has an ultimate completion date of January 15, 2025 and does not utilize any set-aside requirements. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,028.06 firm-fixed-price delivery order to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of 4565781870 DIHYDROERGOTAMINE 4 MG/ML SPRYML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of pharmaceutical and medical supplies to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,703.78 firm fixed-price delivery order (SPE2DX15D1053|SPE2DX25F6JFN) is for the supply of dihydroergotamine 1 mg/ml ampules, with a completion date of February 21, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- The Defense Logistics Agency (DLA) awarded a $1,209.04 delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 8, 2026, for the supply of Dihydroergotamine 4 mg/ml SpryML, with a completion date of January 9, 2026. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen Drug Corp maintains its corporate headquarters. Amerisourcebergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,757.04 to AmerisourceBergen Drug Corp for the supply of Dihydroergotamine 1 mg/ml ampules. This firm fixed-price delivery order, awarded on December 22, 2025, with an ultimate completion date of December 23, 2025, represents a pediatric migraine treatment pharmaceutical product to be delivered to the place of performance in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation,...
- This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order worth $8,716.00 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DIHYDROERGOTAMINE 1 MG/ML AMPML, a pharmaceutical product, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held...
- This is a $1,495.59 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of various pharmaceutical products and medical supplies, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,965.60 firm fixed-price delivery order is for the supply of various pharmaceutical and medical products, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, hormones, and antibiotics. The delivery order is part of AmerisourceBergen's larger...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order, valued at $1,095.34, is to provide a variety of pharmaceutical products and medical supplies to support military treatment programs and facilities. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY4RMDelivery Order
This is a $1,775.91 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of dihydroergotamine 1 mg/ml ampules, a prescription medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific delivery order does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 4/15/24 |